Prospective, randomized, double-blind, placebo-controlled trial of marimastat after response to first-line chemotherapy in patients with small-cell lung cancer: A trial of the National Cancer Institute of Canada-Clinical Trials Group and the European Organization for Research and Treatment of Cancer

Frances A. Shepherd, Giuseppe Giaccone, Lesley Seymour, Channa Debruyne, Andrea Bezjak, Vera Hirsh, Michael Smylie, Sheldon Rubin, Heidi Martins, Alan Lamont, Maciej Krzakowski, Anna Sadura, Benny Zee

Producción científica: Contribución a una revista › Artículo › revisión exhaustiva

246 Citas (Scopus)

Huella

Profundice en los temas de investigación de 'Prospective, randomized, double-blind, placebo-controlled trial of marimastat after response to first-line chemotherapy in patients with small-cell lung cancer: A trial of the National Cancer Institute of Canada-Clinical Trials Group and the European Organization for Research and Treatment of Cancer'. En conjunto forman una huella única.

Medicine & Life Sciences